|
|
|
Summary
of 2002 CPCRA Posters and Presentations 10/02
| 6th International Congress on Drug Therapy In HIV Infection, Glasgow, Scotland, November 17-21, 2002 |
Perez
G, MacArthur R, Walmsley S, Baxter J, Mullin C, Neaton J, Schmetter
B. A multinational randomized clinical endpoint study comparing
nelfinavir and ritonavir in 775 patients for the Terry Beirn Community
Programs for Clinical Research on AIDS and the Canadian HIV trials
Network. Poster, Abstract Number: P43.
| XIV International
AIDS Conference, July 7-12, 2002, Barcelona, Spain |
Fehmida
Visnegarwala, M.D.Insulin resistance (IR) and prevalence of diabetes
melitus (DM) in antiretroviral (ARV) naive patients coinfected with
hepatitis C (HCV) and HIV-1 compared to patients with HIV-1 infection
alone. Oral, July 10, 2002, Abstract Number: WePeB5921.
Shlay
J, El-Sadr W, Bartsch G, Mullin C, Gibert C, Visnegarwala F, Carr
A, Rappoport C, Raghavan S. Development of a Simple Questionnaire
to Assess Changes in Body Appearance among Antiretroviral (AR) Naïve
HIV-Infected Patients (pts). Abstract number: B11029; published on the Conference CD-ROM, an extension of the Abstract Book.
El-Sadr
W. Design of a large study to evaluate two strategies for the use
of antiretroviral drugs: the SMART study. Abstract number is: B11175
XIV; published on the Conference CD-ROM, an extension of the Abstract Book.
El-Sadr
W, Bartsch G, Carr A, Mullin C, Visnegarwala F, Rappoport C, Gibert
C, Raghavan S. The Effect of HIV Disease and Demographic factors
on Lipid Parameters in a Large Antiretroviral Naïve Cohort. Abstract Number: B11177; published on the Conference CD-ROM, an extension of the Abstract Book.
| 6th International
Workshop on HIV Drug Resistance and Treatment Strategies,
July 2, 2002 |
Lawrence
J, Mayers D, Huppler Hullsiek K, Schmetter B, Abrams D, Baxter J.
Simultaneous Genotypic and Phenotypic HIV Resistance Testing and
Influence on Treatment Selection in the CPCRA 064 (MDR) Study. Abstract
number: B11177 XIV
| 9th Conference
on Retroviruses and Opportunistic Infections on February 24,
2002 |
Reisler
R, Han C, Burman W, Tedaldi E, Neaton J. Risk of Grade IV Adverse
Events and Death in HIV Patients Co-infected with Hepatitis B and/or
C Receiving HAART. Poster, Session 87, Abstract Number: 657-M.
Reisler
R, Han C, Burman W, Tedaldi E, Neaton J. Incidence of Grade IV Clinical
Events, AIDS, and Mortality in Large Multic-Center Cohort Receiving
HAART. Oral, Session 7, February 25, 2002, Abstract Number: 36.
Burman
W, El-Sadr W, Matts J, Hafner R, Crane L, Gordin F. Continued Low
Rates of Mycobacterium avium complex (MAC) and Bacterial Pneumonia
Despite Withdrawal of Azithromycin Prophylaxis Among Patients With
CD4 Cell Rebound. Poster, Session 83, Abstract Number: 631-W.
|
|
